ARCHIVES

Nancy Brinker Resigns As CEO of Komen

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

Ivax Paclitaxel To Remain On Market In Deal With BMS.

February 1, 2002

New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together

June 3, 1994

As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer.

February 22, 2008

Breast Cancer Coalition Plans Petition Urging Comprehensive Strategy

May 14, 1993

NCI Begins Phase III Trial Of Shark Cartilage In NSCLC.

May 25, 2001

$150 Mil. For Army Breast Cancer Program Urged In Letter

September 16, 1994